BRIEF-VM Biopharma obtained INDA from Korean healh regulator for mid-stage trial of gene therapy drug

* Obtained inda from ministry of food and drug safety in

korea for phase ii clinical trial of investigational gene

therapy drug, vm202

Source text for Eikon:

Further company coverage:

(Bengaluru...

Read more